Cerebrovascular accident, stroke
The Atlas of Heart Disease and Stroke
An estimated 17 million people die of CVDs, particularly heart attacks and strokes, every year. A substantial number of these deaths can be attributed to tobacco smoking, which increases the risk of dying from coronary heart disease and cerebrovascular disease 2–3 fold. Physical inactivity and unhealthy diet are other main risk factors which increase individual risks to cardiovascular diseases. One of the strategies to respond to the challenges to population health and well being due to the global epidemic of heart attack and stroke is to provide actionable information for development and implementation of appropriate policies. As part of such efforts, WHO in collaboration with the US Centers for Disease Control and Prevention (CDC) has produced for the wider audience, "The Atlas of Heart Disease and Stroke".
The atlas addresses the global epidemic of heart disease and stroke in a clear and accessible format. This highly valuable reference material has been designed for use by policy makers, national and international organizations, health professionals and the general public. This picturesque atlas is in six parts: cardiovascular disease; risk factors; the burden; action; the future and the past; and world tables.
All topics of contemporary importance have been addressed in this atlas in succinctly summarized format such that the points are powerfully communicated in not many words on a few pages.
Prevention of recurrent heart attacks and strokes in low and middle income populations
Evidence-based recommendations for policy makers and health professionals.
This publication summarizes the evidence for the effectiveness of interventions for secondary prevention of coronary heart disease (CHD) and cerebrovascular disease (CeVD). A commentary on the evidence for cardiovascular prevention in peripheral vascular disease and diabetes is also included.
Each review of evidence is followed by a short summary of clinical recommendations for secondary prevention. A review of other considerations influencing policy-makers in the implementation of secondary prevention strategies, including health economics, follows. Finally, the book identifies areas in which research is needed to improve secondary prevention of CVD in low- and middle-income populations.
This publication is intended for practicing physicians responsible for the care of patients with established cardiovascular disease (CVD) - specifically CHD and CeVD - in low- and middle-income populations and countries. The aim is to provide general guidance about the effectiveness - or lack of effectiveness - of specific interventions, both pharmacological and non-pharmacological.
In addition, the information will help a wide range of health professionals concerned with individual and community care, and will provide guidance to health policy-makers about the broader issues pertaining to implementation of interventions in low- and middle-income populations.